Xefta 250 mg Gefitinib Tablets

Medicine Detail

Brand: Xefta

Content: Gefitinib 250 mg

Strength: 250 mg

From: Tablets

Manufacturer: Dr. Reddy's Laboratories Ltd


Xefta 250 mg Tablet helps to relieve the extreme pain and discomfort suffered by patients of breast or lung cancers. It slows down the production of cancer cells, thereby inhibiting the spread of the malignant tissues. It can be administered orally with or without food.


Xefta 250 mg Tablet is an anticancer medicine which is used in the treatment of cancer of the lungs. It should only be used under the supervision of a qualified physician. This medicine is not recommended for use in patients with lung and liver diseases.

Xefta 250mg Tablet is used in the treatment of non-small cell lung cancer.
It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Xefta Tablet is used for Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations and other conditions. Xefta Tablet may also be used for purposes not listed in this medication guide.

Xefta Tablet contains Gefitinib as an active ingredient.

Xefta Tablet works by blocking signalling of epidermal growth factor receptor dependent proliferation.

Dr Reddy's Labs manufactures Xefta Tablet.


Xefta Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

Treatment of metastatic non-small cell lung cancer in tumors with epidermal growth factor receptor exon 19 deletions or exon 21 substitution mutations.

Xefta Tablet may also be used for purposes not listed here.





Loss of appetite

Dry skin


Stomatitis (Inflammation of the mouth).


Before using Xefta Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

Avoid concomitant use of this drug with proton pump inhibitors

Contact doctor for new onset or worsening of pulmonary symptoms such as dyspnea, cough and fever

Contact doctor for severe or persistent diarrhea

Contact doctor if developing eye symptoms, lacrimation, light sensitivity, blurred vision, eye pain, red eye, or changes in vision

Discontinue breast-feeding during treatment with this drug

If treatment with a proton-pump inhibitor is required, take this drug 12 hours after the last dose or 12 hours before the next dose of the proton-pump inhibitor.

Write a review

Note: HTML is not translated!
    Bad           Good

Tags: Xefta Tablets, Gefitinib Tablets.